SANGAMO THERAPEUTICS, INC financial data

Symbol
SGMO on Nasdaq
Location
Richmond, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 95% % -38%
Debt-to-equity 599% % 309%
Return On Assets -116% % -7.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 336,494,489 shares 61%
Common Stock, Shares, Outstanding 212,837,679 shares 19%
Entity Public Float $74,246,155 USD -68%
Common Stock, Value, Issued $3,220,000 USD 54%
Weighted Average Number of Shares Outstanding, Basic 304,268,000 shares 46%
Weighted Average Number of Shares Outstanding, Diluted 304,268,000 shares 42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $32,875,000 USD -37%
Research and Development Expense $104,907,000 USD -24%
General and Administrative Expense $36,994,000 USD -23%
Operating Income (Loss) $109,026,000 USD 22%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $109,351,000 USD 19%
Income Tax Expense (Benefit) $442,000 USD -3583%
Net Income (Loss) Attributable to Parent $108,909,000 USD 19%
Earnings Per Share, Basic 0 USD/shares 45%
Earnings Per Share, Diluted 0 USD/shares 46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $29,616,000 USD -24%
Accounts Receivable, after Allowance for Credit Loss, Current $523,000 USD -95%
Assets, Current $44,076,000 USD -24%
Property, Plant and Equipment, Net $14,794,000 USD -23%
Operating Lease, Right-of-Use Asset $14,428,000 USD -19%
Intangible Assets, Net (Excluding Goodwill) $0 USD
Goodwill $0 USD
Other Assets, Noncurrent $871,000 USD
Assets $88,643,000 USD -20%
Accounts Payable, Current $15,556,000 USD -21%
Accrued Liabilities, Current $9,868,000 USD -15%
Contract with Customer, Liability, Current $7,556,000 USD 876%
Liabilities, Current $50,125,000 USD 16%
Contract with Customer, Liability, Noncurrent $5,874,000 USD
Deferred Income Tax Liabilities, Net $15,000 USD
Operating Lease, Liability, Noncurrent $25,424,000 USD -8.3%
Other Liabilities, Noncurrent $977,000 USD -21%
Liabilities $82,400,000 USD 14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,445,000 USD 66%
Retained Earnings (Accumulated Deficit) $1,589,830,000 USD -7.4%
Stockholders' Equity Attributable to Parent $6,243,000 USD -84%
Liabilities and Equity $88,643,000 USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $26,149,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $8,134,000 USD -63%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 960,000,000 shares 0%
Common Stock, Shares, Issued 212,837,679 shares 19%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $16,738,000 USD -294%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30,528,000 USD -25%
Deferred Tax Assets, Valuation Allowance $367,578,000 USD 4.6%
Deferred Tax Assets, Gross $371,257,000 USD 3.9%
Operating Lease, Liability $30,566,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $106,131,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid $37,014,000 USD -18%
Property, Plant and Equipment, Gross $57,705,000 USD -26%
Operating Lease, Liability, Current $4,313,000 USD -6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,372,000 USD -2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,708,000 USD -1.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 36%
Deferred Income Tax Expense (Benefit) $15,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,205,000 USD -9.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,319,000 USD -2.9%
Deferred Tax Assets, Operating Loss Carryforwards $211,585,000 USD 7.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $22,137,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,496,000 USD 0.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,020,000 USD -27%
Deferred Tax Assets, Net of Valuation Allowance $3,679,000 USD -36%
Share-based Payment Arrangement, Expense $10,232,000 USD -33%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%